Table 1 Demographic characteristics of study patients, overall and by the main subgroups with (NP) and without (NNP) associated neuropathic component.
Variable | Total | NP | NNP |
|---|---|---|---|
N | 158 | 99 (62.7%) | 59 (37.3%) |
Sex, females; n (%) | 93 (58.9%) | 46 (47%)† | 47 (80%) |
Race (Caucasian); n (%) | 149 (95.5%) | 93 (94%) | 56 (98%) |
Age (years) | 60.1 (15.9) | 57.2 (15.2)† | 64.9 (16.1) |
BMI (kg/m2) | 27.3 (4.6) | 27.3 (4.1) | 27.2 (5.4) |
Drug therapy; | |||
n (%): | 145 (91.8%) | 89 (90%) | 56 (95%) |
no. of drugs: a | 2.0 (1.0 – 3.0) | 2.0 (1.0 – 3.0) | 2.0 (1.0 – 3.0) |
Educational level; n (%)† | |||
No studies: | 39 (25.0%) | 19 (19%) | 20 (35%) |
Primary school: | 69 (44.2%) | 45 (46%) | 24 (41%) |
High school: | 14 (9.0%) | 12 (12%) | 2 (3%) |
Vocational training: | 16 (10.3%) | 14 (14%) | 2 (3%) |
Graduate studies: | 18 (11.5%) | 8 (8%) | 10 (17%) |
SF-MPQ scoring; | |||
Sensory dimension (0 – 33): | 12.4 (6.4) | 13.1 (6.0) | 11.3 (6.8) |
Affective dimension (0 – 12): | 4.9 (3.6) | 4.8 (3.6) | 5.2 (3.6) |
Total score (0 – 45): | 17.4 (8.3) | 17.9 (8.1) | 16.5 (8.8) |
Pain in the previous week (VAS; 0 – 100): | 65.4 (20.7) | 65.6 (22.2) | 65.0 (18.2) |